TPAP for Comfort in OSA - Trial NCT06264128
Access comprehensive clinical trial information for NCT06264128 through Pure Global AI's free database. This phase not specified trial is sponsored by SleepRes Inc. and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
SleepRes Inc.
Timeline & Enrollment
N/A
Mar 08, 2024
Jun 30, 2024
Primary Outcome
CPAP v TPAP Patient Preference via Visual Analog Scale
Summary
TheraPAP is a prototype device (with full documented electrical and isolation safety) being
 developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver
 either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control
 algorithm that lowers the pressure from the set pressure at the beginning of inspiration and
 does not return the pressure to the full set level until about halfway through expiration.
 The present study, TheraPAP Comfort, aims at assessing whether TPAP improves patient comfort
 vs. CPAP during supine wakefulness.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06264128
Device Trial